IPSEN (IPN.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:IPN • FR0010259150

136.1 EUR
-1.3 (-0.95%)
Last: Feb 3, 2026, 07:00 PM
Fundamental Rating

6

IPN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. IPN has an excellent financial health rating, but there are some minor concerns on its profitability. IPN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year IPN was profitable.
  • IPN had a positive operating cash flow in the past year.
  • Each year in the past 5 years IPN has been profitable.
  • IPN had a positive operating cash flow in each of the past 5 years.
IPN.PA Yearly Net Income VS EBIT VS OCF VS FCFIPN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • IPN's Return On Assets of 6.56% is in line compared to the rest of the industry. IPN outperforms 52.73% of its industry peers.
  • IPN has a Return On Equity (10.59%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of IPN (14.89%) is better than 74.55% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for IPN is in line with the industry average of 14.23%.
  • The 3 year average ROIC (12.97%) for IPN is below the current ROIC(14.89%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.56%
ROE 10.59%
ROIC 14.89%
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
IPN.PA Yearly ROA, ROE, ROICIPN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

  • With a Profit Margin value of 11.92%, IPN perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
  • In the last couple of years the Profit Margin of IPN has declined.
  • The Operating Margin of IPN (26.02%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of IPN has declined.
  • IPN's Gross Margin of 83.32% is amongst the best of the industry. IPN outperforms 87.27% of its industry peers.
  • IPN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.02%
PM (TTM) 11.92%
GM 83.32%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
IPN.PA Yearly Profit, Operating, Gross MarginsIPN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IPN is creating value.
  • IPN has more shares outstanding than it did 1 year ago.
  • IPN has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for IPN has been reduced compared to a year ago.
IPN.PA Yearly Shares OutstandingIPN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
IPN.PA Yearly Total Debt VS Total AssetsIPN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • IPN has an Altman-Z score of 4.78. This indicates that IPN is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.78, IPN is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
  • The Debt to FCF ratio of IPN is 1.46, which is an excellent value as it means it would take IPN, only 1.46 years of fcf income to pay off all of its debts.
  • IPN has a better Debt to FCF ratio (1.46) than 89.09% of its industry peers.
  • IPN has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
  • IPN's Debt to Equity ratio of 0.20 is fine compared to the rest of the industry. IPN outperforms 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.46
Altman-Z 4.78
ROIC/WACC1.87
WACC7.95%
IPN.PA Yearly LT Debt VS Equity VS FCFIPN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • IPN has a Current Ratio of 1.98. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
  • IPN's Current ratio of 1.98 is fine compared to the rest of the industry. IPN outperforms 70.91% of its industry peers.
  • A Quick Ratio of 1.80 indicates that IPN should not have too much problems paying its short term obligations.
  • The Quick ratio of IPN (1.80) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.8
IPN.PA Yearly Current Assets VS Current LiabilitesIPN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 12.24% over the past year.
  • IPN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.79% yearly.
  • IPN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.45%.
  • Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%

3.2 Future

  • IPN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.43% yearly.
  • IPN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.42% yearly.
EPS Next Y10.38%
EPS Next 2Y5.39%
EPS Next 3Y4.79%
EPS Next 5Y5.43%
Revenue Next Year8.8%
Revenue Next 2Y6.24%
Revenue Next 3Y6.01%
Revenue Next 5Y4.42%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IPN.PA Yearly Revenue VS EstimatesIPN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
IPN.PA Yearly EPS VS EstimatesIPN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 13.25, IPN is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 74.55% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of IPN to the average of the S&P500 Index (28.18), we can say IPN is valued rather cheaply.
  • The Price/Forward Earnings ratio is 11.93, which indicates a very decent valuation of IPN.
  • Based on the Price/Forward Earnings ratio, IPN is valued a bit cheaper than the industry average as 76.36% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 25.51. IPN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.25
Fwd PE 11.93
IPN.PA Price Earnings VS Forward Price EarningsIPN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IPN is valued cheaper than 94.55% of the companies in the same industry.
  • IPN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IPN is cheaper than 72.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.18
EV/EBITDA 6.53
IPN.PA Per share dataIPN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • IPN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.28
PEG (5Y)1.51
EPS Next 2Y5.39%
EPS Next 3Y4.79%

More info and screens

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.02%, IPN has a reasonable but not impressive dividend return.
  • IPN's Dividend Yield is comparable with the industry average which is at 1.95.
  • Compared to an average S&P500 Dividend Yield of 1.83, IPN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.02%

5.2 History

  • The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
IPN.PA Yearly Dividends per shareIPN.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • IPN pays out 25.94% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of IPN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.94%
EPS Next 2Y5.39%
EPS Next 3Y4.79%
IPN.PA Yearly Income VS Free CF VS DividendIPN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
IPN.PA Dividend Payout.IPN.PA Dividend Payout, showing the Payout Ratio.IPN.PA Dividend Payout.PayoutRetained Earnings

More info and screens

IPSEN

EPA:IPN (2/3/2026, 7:00:00 PM)

136.1

-1.3 (-0.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-22
Earnings (Next)02-12
Inst Owners15.35%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap11.41B
Revenue(TTM)3.76B
Net Income(TTM)448.00M
Analysts68.89
Price Target131.03 (-3.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.02%
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.94%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.65%
PT rev (3m)-0.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.27%
EPS NY rev (3m)4.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.62%
Valuation
Industry RankSector Rank
PE 13.25
Fwd PE 11.93
P/S 3.03
P/FCF 19.18
P/OCF 11.68
P/B 2.7
P/tB 8.54
EV/EBITDA 6.53
EPS(TTM)10.27
EY7.55%
EPS(NY)11.41
Fwd EY8.38%
FCF(TTM)7.1
FCFY5.21%
OCF(TTM)11.65
OCFY8.56%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)1.28
PEG (5Y)1.51
Graham Number107.98
Profitability
Industry RankSector Rank
ROA 6.56%
ROE 10.59%
ROCE 18.08%
ROIC 14.89%
ROICexc 20.47%
ROICexgc 77.3%
OM 26.02%
PM (TTM) 11.92%
GM 83.32%
FCFM 15.82%
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.46
Debt/EBITDA 0.5
Cap/Depr 55.61%
Cap/Sales 10.16%
Interest Coverage 250
Cash Conversion 58.65%
Profit Quality 132.77%
Current Ratio 1.98
Quick Ratio 1.8
Altman-Z 4.78
F-Score7
WACC7.95%
ROIC/WACC1.87
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y10.38%
EPS Next 2Y5.39%
EPS Next 3Y4.79%
EPS Next 5Y5.43%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year8.8%
Revenue Next 2Y6.24%
Revenue Next 3Y6.01%
Revenue Next 5Y4.42%
EBIT growth 1Y66.82%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year41.46%
EBIT Next 3Y13.73%
EBIT Next 5Y7.49%
FCF growth 1Y-23.46%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-0.85%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%

IPSEN / IPN.PA FAQ

What is the fundamental rating for IPN stock?

ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.


What is the valuation status of IPSEN (IPN.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for IPSEN?

IPSEN (IPN.PA) has a profitability rating of 6 / 10.


What is the financial health of IPSEN (IPN.PA) stock?

The financial health rating of IPSEN (IPN.PA) is 7 / 10.


How sustainable is the dividend of IPSEN (IPN.PA) stock?

The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.94%.